Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Clinical trial NCT02299089 · COMPLETED

Trial details

NCT number: NCT02299089
Sponsor: Camurus AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acromegaly Neuroendocrine Tumors

Start date: 2015-01-01
Primary completion: 2016-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.